{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:20:31Z","timestamp":1780050031197,"version":"3.53.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"crossref","award":["19\/082"],"award-info":[{"award-number":["19\/082"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Womens Ment Health"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s00737-021-01179-4","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T04:02:31Z","timestamp":1631160151000},"page":"9-19","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Rate of polycystic ovary syndrome in mental health disorders: a systematic review"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5344-2959","authenticated-orcid":false,"given":"Katie M.","family":"Douglas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna J.","family":"Fenton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Eggleston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,9]]},"reference":[{"issue":"2","key":"1179_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1600-0447.1996.tb09838.x","volume":"94","author":"L Bergman","year":"1996","unstructured":"Bergman L, Eriksson E (1996) Marked symptom reduction in two women with bulimia nervosa treated with the testosterone receptor antagonist flutamide. Acta Psychiatr Scand 94(2):137\u2013139","journal-title":"Acta Psychiatr Scand"},{"issue":"12","key":"1179_CR2","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/humrep\/dew218","volume":"31","author":"G Bozdag","year":"2016","unstructured":"Bozdag G, Mumusoglu S, Zengin D et al (2016) The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 31(12):2841\u20132855","journal-title":"Hum Reprod"},{"issue":"2","key":"1179_CR3","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s12020-018-1692-3","volume":"62","author":"C Brutocao","year":"2018","unstructured":"Brutocao C, Zaiem F, Alsawas M et al (2018) Psychiatric disorders in women with polycystic ovary syndrome: a systematic review and meta-analysis. Endocrine 62(2):318\u2013325","journal-title":"Endocrine"},{"issue":"1","key":"1179_CR4","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41398-018-0186-7","volume":"8","author":"A Cherskov","year":"2018","unstructured":"Cherskov A, Pohl A, Allison C et al (2018) Polycystic ovary syndrome and autism: A test of the prenatal sex steroid theory. Transl Psychiatry 8(1):136","journal-title":"Transl Psychiatry"},{"issue":"2","key":"1179_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1365-2265.1992.tb02296.x","volume":"37","author":"RN Clayton","year":"1992","unstructured":"Clayton RN, Ogden V, Hodgkinson J et al (1992) How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? Clin Endocrinol 37(2):127\u2013134","journal-title":"Clin Endocrinol"},{"issue":"5","key":"1179_CR6","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/humrep\/dex044","volume":"32","author":"LG Cooney","year":"2017","unstructured":"Cooney LG, Lee I, Sammel MD et al (2017) High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 32(5):1075\u20131091","journal-title":"Hum Reprod"},{"issue":"4","key":"1179_CR7","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1001\/archinte.164.4.394","volume":"164","author":"DJ Dobie","year":"2004","unstructured":"Dobie DJ, Kivlahan DR, Maynard C et al (2004) Posttraumatic stress disorder in female veterans: association with self-reported health problems and functional impairment. Arch Intern Med 164(4):394\u2013400","journal-title":"Arch Intern Med"},{"issue":"6","key":"1179_CR8","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.psyneuen.2011.09.005","volume":"37","author":"O Eriksson","year":"2012","unstructured":"Eriksson O, Landen M, Sundblad C et al (2012) Ovarian morphology in premenstrual dysphoria. Psychoneuroendocrinology 37(6):742\u2013751","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"1179_CR9","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.yhbeh.2007.02.001","volume":"51","author":"E Ingudomnukul","year":"2007","unstructured":"Ingudomnukul E, Baron-Cohen S, Wheelwright S et al (2007) Elevated rates of testosterone-related disorders in women with autism spectrum conditions. Horm Behav 51(5):597\u2013604","journal-title":"Horm Behav"},{"issue":"11","key":"1179_CR10","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.biopsych.2005.10.017","volume":"59","author":"H Joffe","year":"2006","unstructured":"Joffe H, Cohen LS, Suppes T et al (2006) Valproate is associated with new-onset oligoamenorrhea with hyperandrogenism in women with bipolar disorder. Biol Psychiat 59(11):1078\u20131086","journal-title":"Biol Psychiat"},{"key":"1179_CR11","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1196\/annals.1429.030","volume":"1135","author":"H Joffe","year":"2008","unstructured":"Joffe H, Hayes FJ (2008) Menstrual cycle dysfunction associated with neurologic and psychiatric disorders: their treatment in adolescents. Ann N Y Acad Sci 1135:219\u2013229","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl 2","key":"1179_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0306-4530(02)00130-0","volume":"28","author":"H Knegtering","year":"2003","unstructured":"Knegtering H, van der Moolen AE, Castelein S et al (2003) What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning? Psychoneuroendocrinology 28(Suppl 2):109\u2013123","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"1179_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/0004867420979353","volume":"55","author":"GS Malhi","year":"2021","unstructured":"Malhi GS, Bell E, Bassett D et al (2021) The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry 55(1):7\u2013117","journal-title":"Aust N Z J Psychiatry"},{"issue":"1","key":"1179_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1034\/j.1399-5618.2003.00009.x","volume":"5","author":"RS McIntyre","year":"2003","unstructured":"McIntyre RS, Mancini DA, McCann S et al (2003) Valproate, bipolar disorder and polycystic ovarian syndrome. Bipolar Disord 5(1):28\u201335","journal-title":"Bipolar Disord"},{"issue":"3","key":"1179_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/XEB.0000000000000054","volume":"13","author":"Z Munn","year":"2015","unstructured":"Munn Z, Moola S, Lisy K et al (2015) Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid Based Healthc 13(3):147\u2013153","journal-title":"Int J Evid Based Healthc"},{"issue":"7","key":"1179_CR16","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1080\/09513590600847421","volume":"22","author":"S Naessen","year":"2006","unstructured":"Naessen S, Carlstrom K, Garoff L et al (2006) Polycystic ovary syndrome in bulimic women\u2013an evaluation based on the new diagnostic criteria. Gynecol Endocrinol 22(7):388\u2013394","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"1179_CR17","first-page":"336","volume":"38","author":"UA Ndefo","year":"2013","unstructured":"Ndefo UA, Eaton A, Green MR (2013) Polycystic ovary syndrome: a review of treatment options with a focus on pharmacological approaches. P T 38(6):336\u2013355","journal-title":"P T"},{"issue":"4","key":"1179_CR18","doi-asserted-by":"publisher","first-page":"322","DOI":"10.4088\/JCP.v63n0409","volume":"63","author":"C O'Donovan","year":"2002","unstructured":"O\u2019Donovan C, Kusumakar V, Graves GR et al (2002) Menstrual abnormalities and polycystic ovary syndrome in women taking valproate for bipolar mood disorder. J Clin Psychiatry 63(4):322\u2013330","journal-title":"J Clin Psychiatry"},{"issue":"8590","key":"1179_CR19","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/S0140-6736(88)91612-1","volume":"1","author":"DW Polson","year":"1988","unstructured":"Polson DW, Adams J, Wadsworth J et al (1988) Polycystic ovaries\u2013a common finding in normal women. Lancet 1(8590):870\u2013872","journal-title":"Lancet"},{"issue":"2","key":"1179_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4103\/IJPSYM.IJPSYM_284_17","volume":"40","author":"S Qadri","year":"2018","unstructured":"Qadri S, Hussain A, Bhat MH et al (2018) Polycystic Ovary Syndrome in Bipolar Affective Disorder: A Hospital-based Study. Indian J Psychol Med 40(2):121\u2013128","journal-title":"Indian J Psychol Med"},{"issue":"4","key":"1179_CR21","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1365-2265.1995.tb02617.x","volume":"43","author":"FJ Raphael","year":"1995","unstructured":"Raphael FJ, Rodin DA, Peattie A et al (1995) Ovarian morphology and insulin sensitivity in women with bulimia nervosa. Clin Endocrinol 43(4):451\u2013455","journal-title":"Clin Endocrinol"},{"issue":"3","key":"1179_CR22","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1399-5618.2005.00201.x","volume":"7","author":"NL Rasgon","year":"2005","unstructured":"Rasgon NL, Altshuler LL, Fairbanks L et al (2005) Reproductive function and risk for PCOS in women treated for bipolar disorder. Bipolar Disord 7(3):246\u2013259","journal-title":"Bipolar Disord"},{"issue":"3","key":"1179_CR23","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4088\/JCP.v61n0305","volume":"61","author":"NL Rasgon","year":"2000","unstructured":"Rasgon NL, Altshuler LL, Gudeman D et al (2000) Medication status and polycystic ovary syndrome in women with bipolar disorder: a preliminary report. J Clin Psychiatry 61(3):173\u2013178","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"1179_CR24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/bdi.12149","volume":"16","author":"MF Reynolds-May","year":"2014","unstructured":"Reynolds-May MF, Kenna HA, Marsh W et al (2014) Evaluation of reproductive function in women treated for bipolar disorder compared to healthy controls. Bipolar Disord 16(1):37\u201347","journal-title":"Bipolar Disord"},{"issue":"13","key":"1179_CR25","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jpsychires.2010.01.007","volume":"44","author":"S Roepke","year":"2010","unstructured":"Roepke S, Ziegenhorn A, Kronsbein J et al (2010) Incidence of polycystic ovaries and androgen serum levels in women with borderline personality disorder. J Psychiatr Res 44(13):847\u2013852","journal-title":"J Psychiatr Res"},{"issue":"5","key":"1179_CR26","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1093\/schbul\/sbn023","volume":"35","author":"MV Seeman","year":"2009","unstructured":"Seeman MV (2009) Secondary effects of antipsychotics: women at greater risk than men. Schizophr Bull 35(5):937\u2013948","journal-title":"Schizophr Bull"},{"issue":"1","key":"1179_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/01.jcp.0000150222.31007.a9","volume":"25","author":"C Sundblad","year":"2005","unstructured":"Sundblad C, Landen M, Eriksson T et al (2005) Effects of the androgen antagonist flutamide and the serotonin reuptake inhibitor citalopram in bulimia nervosa: a placebo-controlled pilot study. J Clin Psychopharmacol 25(1):85\u201388","journal-title":"J Clin Psychopharmacol"},{"key":"1179_CR28","doi-asserted-by":"crossref","unstructured":"Teede H, Deeks A and Moran L (2010) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med 8: 41","DOI":"10.1186\/1741-7015-8-41"},{"issue":"9","key":"1179_CR29","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/humrep\/dey256","volume":"33","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, Misso ML, Costello MF et al (2018) Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod 33(9):1602\u20131618","journal-title":"Hum Reprod"},{"issue":"3","key":"1179_CR30","doi-asserted-by":"publisher","first-page":"339","DOI":"10.4103\/0972-2327.179973","volume":"19","author":"LG Viswanathan","year":"2016","unstructured":"Viswanathan LG, Satishchandra P, Bhimani BC et al (2016) Polycystic ovary syndrome in patients on antiepileptic drugs. Ann Indian Acad Neurol 19(3):339\u2013343","journal-title":"Ann Indian Acad Neurol"},{"key":"1179_CR31","doi-asserted-by":"crossref","unstructured":"Wolf WM, Wattick RA, Kinkade ON, et al. (2018) Geographical Prevalence of Polycystic Ovary Syndrome as Determined by Region and Race\/Ethnicity. Int J Environ Res Public Health 15(11)","DOI":"10.3390\/ijerph15112589"},{"key":"1179_CR32","doi-asserted-by":"publisher","unstructured":"2013 Young AH and Grunze H (2013) Physical health of patients with bipolar disorder. Acta Psychiatrica Scandinavica. Supplementum (442) 3\u201310. https:\/\/doi.org\/10.1111\/acps.12117","DOI":"10.1111\/acps.12117"},{"key":"1179_CR33","doi-asserted-by":"crossref","unstructured":"Zargar AH, Gupta VK, Wani AI, et al. (2005) Prevalence of ultrasonography proved polycystic ovaries in North Indian women with type 2 diabetes mellitus. Reprod Biol Endocrinol 3: 35","DOI":"10.1186\/1477-7827-3-35"},{"key":"1179_CR34","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ejogrb.2016.04.038","volume":"202","author":"L Zhang","year":"2016","unstructured":"Zhang L, Li H, Li S et al (2016) Reproductive and metabolic abnormalities in women taking valproate for bipolar disorder: a meta-analysis. Eur J Obstet Gynecol Reprod Biol 202:26\u201331","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["Archives of Women's Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00737-021-01179-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00737-021-01179-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00737-021-01179-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T05:23:18Z","timestamp":1643088198000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00737-021-01179-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,9]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1179"],"URL":"https:\/\/doi.org\/10.1007\/s00737-021-01179-4","relation":{},"ISSN":["1434-1816","1435-1102"],"issn-type":[{"value":"1434-1816","type":"print"},{"value":"1435-1102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,9]]},"assertion":[{"value":"1 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NA","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"NA","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"NA","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"RP and KD have used software provided by Scientific Brain Training Pro (SBT-Pro) for research at no cost. RP has received support for travel to educational meetings from Servier and Lundbeck.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}